<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-PNWON93</udiDi>
    <basicUdiDi>B-PNWON93</basicUdiDi>
    <tradeName>Parenteral nutrition bag</tradeName>
    <deviceName>Parenteral Nutrient Infusion Sets for Single Use</deviceName>
    <manufacturerName>Jiangsu Kangjin Medical Instrument Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000011142</manufacturerSrn>
    <authorisedRepresentativeName>Shanghai International Holding Corp. GmbH(Europe)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000001</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>A080102</emdnCode>
    <emdnDescription>PARENTERAL FEEDING BAGS AND CONTAINERS (INCLUDING THOSE VIA PUMP), SINGLE-USE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>many</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:56.849Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40148QC</udiDi>
    <basicUdiDi>B-PN40148QC</basicUdiDi>
    <tradeName>Revanesse Outline+ 1.2 mL</tradeName>
    <deviceName>Revanesse Outline+ 1.2 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40148</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:56.027Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40147QA</udiDi>
    <basicUdiDi>B-PN40147QA</basicUdiDi>
    <tradeName>Revanesse® Outline+ 1.0 mL</tradeName>
    <deviceName>Revanesse® Outline+ 1.0 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40147</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:50.688Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40146Q8</udiDi>
    <basicUdiDi>B-PN40146Q8</basicUdiDi>
    <tradeName>Revanesse Oultine 1.2 mL</tradeName>
    <deviceName>Revanesse Outline 1.2 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40146</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:49.867Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40145Q6</udiDi>
    <basicUdiDi>B-PN40145Q6</basicUdiDi>
    <tradeName>Revanesse Outline</tradeName>
    <deviceName>Revanesse Outline 1.0 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40145</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:49.080Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40143Q2</udiDi>
    <basicUdiDi>B-PN40143Q2</basicUdiDi>
    <tradeName>Revanesse® Outline™ + with Lidocaine 1.0 mL</tradeName>
    <deviceName>Revanesse® Outline + with Lidocaine 1.0 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40143</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:48.292Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40142PY</udiDi>
    <basicUdiDi>B-PN40142PY</basicUdiDi>
    <tradeName>Revanesse® Outline  1.2 mL</tradeName>
    <deviceName>Revanesse® Outline  1.2 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40142</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:44.256Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40141PW</udiDi>
    <basicUdiDi>B-PN40141PW</basicUdiDi>
    <tradeName>Revanesse® Outline 1.0 mL</tradeName>
    <deviceName>Revanesse® Outline   1.0 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40141</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:43.507Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40139QB</udiDi>
    <basicUdiDi>B-PN40139QB</basicUdiDi>
    <tradeName>Revanesse® Revise™ + with Lidocaine  1.2 mL</tradeName>
    <deviceName>Revanesse® Revise + with Lidocaine  1.2 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40139</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:42.658Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40125PY</udiDi>
    <basicUdiDi>B-PN40125PY</basicUdiDi>
    <tradeName>Revanesse Contour XL</tradeName>
    <deviceName>Revanesse® Contour XL  10 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40125</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:41.875Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40116PX</udiDi>
    <basicUdiDi>B-PN40116PX</basicUdiDi>
    <tradeName>Revanesse® Shape  1.2 mL</tradeName>
    <deviceName>Revanesse® Shape  1.2 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40116</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:37.857Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40115PV</udiDi>
    <basicUdiDi>B-PN40115PV</basicUdiDi>
    <tradeName>Revanesse® Outline™ + with Lidocaine  1.2 mL</tradeName>
    <deviceName>Revanesse® Outline + with Lidocaine  1.2 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40115</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:37.793Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40114PT</udiDi>
    <basicUdiDi>B-PN40114PT</basicUdiDi>
    <tradeName>Revanesse® Revise   1.2 mL</tradeName>
    <deviceName>Revanesse® Revise  1.2 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40114</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:37.768Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40112PP</udiDi>
    <basicUdiDi>B-PN40112PP</basicUdiDi>
    <tradeName>Revanesse® Kiss   1.2 mL</tradeName>
    <deviceName>Revanesse® Kiss  1.2 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40112</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:37.764Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40113PR</udiDi>
    <basicUdiDi>B-PN40113PR</basicUdiDi>
    <tradeName>Revanesse® Kiss™ + with Lidocaine 1.2 mL</tradeName>
    <deviceName>Revanesse® Kiss + with Lidocaine 1.2 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40113</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:32.059Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40111PM</udiDi>
    <basicUdiDi>B-PN40111PM</basicUdiDi>
    <tradeName>Revanesse® Contour™ + with Lidocaine 1.2 mL</tradeName>
    <deviceName>Revanesse® Contour + with Lidocaine 1.2 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40111</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:31.379Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40110PK</udiDi>
    <basicUdiDi>B-PN40110PK</basicUdiDi>
    <tradeName>Revanesse® Contour  1.2 mL</tradeName>
    <deviceName>Revanesse® Contour  1.2 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40100</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:30.348Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40107PW</udiDi>
    <basicUdiDi>B-PN40107PW</basicUdiDi>
    <tradeName>Revanesse® Pure™ + with Lidocaine  1.2 mL</tradeName>
    <deviceName>Revanesse® Pure + with Lidocaine  1.2 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40107</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:26.899Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40106PU</udiDi>
    <basicUdiDi>B-PN40106PU</basicUdiDi>
    <tradeName>Revanesse® Pure  1.2 mL</tradeName>
    <deviceName>Revanesse® Pure  1.2 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Revanesse® Pure  1.2 mL</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:24.795Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-PN40103PN</udiDi>
    <basicUdiDi>B-PN40103PN</basicUdiDi>
    <tradeName>Revanesse® Ultra™ + with Lidocaine 1.2 mL</tradeName>
    <deviceName>Revanesse® Ultra + with Lidocaine 1.2 mL</deviceName>
    <manufacturerName>Prollenium Medical Technologies Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000017924</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PN40103</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-14T14:03:24.395Z</lastUpdated>
  </row>
</eudamedExport>